The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 13, 2018
Filed:
Nov. 19, 2013
Applicant:
Agency for Science, Technology and Research, Singapore, SG;
Inventors:
Qiang Yu, Singapore, SG;
Zhen Ning Wee, Singapore, SG;
Assignee:
Agency for Science, Technology and Research, Singapore, SG;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/713 (2006.01); A61K 31/706 (2006.01); A61K 31/437 (2006.01); A61K 38/21 (2006.01); G01N 33/574 (2006.01); C07K 16/40 (2006.01); C07K 14/57 (2006.01); C12Q 1/68 (2018.01); C12N 15/113 (2010.01);
U.S. Cl.
CPC ...
A61K 38/217 (2013.01); A61K 31/437 (2013.01); A61K 31/706 (2013.01); A61K 31/713 (2013.01); C07K 16/40 (2013.01); C12Q 1/6886 (2013.01); G01N 33/57492 (2013.01); G01N 33/57496 (2013.01); C07K 2317/76 (2013.01); C12N 15/1137 (2013.01); C12N 2310/14 (2013.01); C12Y 201/01043 (2013.01); G01N 2800/52 (2013.01);
Abstract
The present invention relates to a pharmaceutical composition comprising a histone-lysine N-methyltransferase EZH2 (enhancer of zeste homolog 2) inhibitor and an enhancer of interferon-gamma receptor activity. The invention also relates to method of treating a patient having cancer, comprising administration of the pharmaceutical composition.